Aligos Therapeutics, Inc. Increase (Decrease) in Deferred Revenue
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-06
- Aligos Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-12-31 was -$168.00K.
- Aligos Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-09-30 was -$411.00K.
- Aligos Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-06-30 was $579.00K, a 4.30% decline year-over-year.
- Aligos Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-03-31 was -$151.00K.
- Aligos Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2025 was -$151.00K.
- Aligos Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2024 was -$1.16M.
- Aligos Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2023 was -$8.13M, a 425.14% decline from fiscal 2022.
- Aligos Therapeutics, Inc. increase (decrease) in deferred revenue for fiscal 2022 was $2.50M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | |||||||
| 2025-12-31 | -$168.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$579.00K derived: sum of 2 quarters · filed 2026-03-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | -$151.00K 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | -$411.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $168.00K derived: sum of 2 quarters · filed 2026-08-06 | $17.00K 10-Q · filed 2025-11-06 | -$487.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $579.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $428.00K 10-Q · filed 2026-08-06 | -$76.00K derived: sum of 3 quarters · filed 2026-08-06 | -$747.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$151.00K 10-Q · filed 2026-05-07 | -$655.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.33M derived: sum of 3 quarters · filed 2026-05-07 | -$721.00K derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | -$504.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$1.18M derived: sum of 2 quarters · filed 2026-03-05 | -$570.00K derived: sum of 3 quarters · filed 2026-03-05 | -$1.16M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | -$671.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$66.00K derived: sum of 2 quarters · filed 2025-11-06 | -$653.00K 10-Q · filed 2025-11-06 | -$84.00K 10-Q · filed 2024-11-06 | -$2.14M derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | $605.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $18.00K 10-Q · filed 2025-08-06 | -$84.00K 10-Q · filed 2024-08-06 | -$1.47M derived: sum of 3 quarters · filed 2025-08-06 | -$3.48M derived: sum of 4 quarters · filed 2025-08-06 | |||
| 2024-03-31 | -$587.00K 10-Q · filed 2025-05-06 | -$84.00K 10-Q · filed 2024-05-07 | -$2.07M derived: sum of 2 quarters · filed 2025-05-06 | -$4.08M derived: sum of 3 quarters · filed 2025-05-06 | -$6.40M derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | -$1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | -$3.50M derived: sum of 2 quarters · filed 2025-03-10 | -$5.81M derived: sum of 3 quarters · filed 2025-03-10 | -$8.13M 10-K · filed 2025-03-10 | -$8.66M 10-K · filed 2024-03-12 | |||
| 2023-09-30 | -$2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$4.33M derived: sum of 2 quarters · filed 2024-11-06 | -$6.65M 10-Q · filed 2024-11-06 | -$8.79M derived: sum of 4 quarters · filed 2024-11-06 | ||||
| 2023-06-30 | -$2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$4.64M 10-Q · filed 2024-08-06 | -$6.78M derived: sum of 3 quarters · filed 2024-08-06 | -$10.88M derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | -$2.32M 10-Q · filed 2024-05-07 | -$4.46M derived: sum of 2 quarters · filed 2024-05-07 | -$8.57M derived: sum of 3 quarters · filed 2024-05-07 | -$12.26M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | -$2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$6.24M derived: sum of 2 quarters · filed 2024-03-12 | -$9.94M derived: sum of 3 quarters · filed 2024-03-12 | $2.50M 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | -$4.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$7.80M derived: sum of 2 quarters · filed 2023-11-02 | $4.64M 10-Q · filed 2023-11-02 | $4.27M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | -$3.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $8.74M 10-Q · filed 2023-08-03 | $8.38M derived: sum of 3 quarters · filed 2023-08-03 | $6.84M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | $12.44M 10-Q · filed 2023-05-04 | $12.07M derived: sum of 2 quarters · filed 2023-05-04 | $10.53M derived: sum of 3 quarters · filed 2023-05-04 | $8.99M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | -$367.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$1.90M derived: sum of 2 quarters · filed 2023-03-09 | -$3.45M derived: sum of 3 quarters · filed 2023-03-09 | -$4.36M 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | -$1.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$3.08M derived: sum of 2 quarters · filed 2021-11-04 | -$3.99M 10-Q · filed 2021-11-04 | |||||
| 2021-06-30 | -$1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$2.46M 10-Q · filed 2021-08-05 | ||||||
| 2021-03-31 | -$910.00K 10-Q · filed 2021-05-10 |